MT 020
Alternative Names: MT-020Latest Information Update: 06 Sep 2024
At a glance
- Originator T-Maximum Pharmaceutical
- Class CAR-T cell therapies; Gene therapies
- Mechanism of Action T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Autoimmune disorders